The Biostatistics Core will provide the personnel and knowledge for the maximum utilization of the data collected by the investigators in the Oral Cancer Research Program Project (OCRPP). Statistical issues will be addressed at every level of investigation; from the design of experiments, to the maintenance of data quality, to the description and inferential statements made from the collected data.
The specific aims of the Biostatistics Core are then: . To collaborate with all OCRPP investigators in protocol design and modification, . To develop and implement a program of data quality control, . To assist in developing and implementing databases for individual laboratories and to plan and implement shared databases, . To conduct statistical analyses of the data generated by OCRPP supported studies in close collaboration with project investigators, . To ensure that new methodologies are developed when needed to serve the work of the program project, and . To ensure that statistical issues are addressed in key program decisions. The Biostatistics Core will be directed by Dr. Dennis Pearl who will have overall responsibility for the activities of the core. Dr. Pearl is a Professor of statistics and Biostatistics with more than 15 years of experience collaborating in cancer related research. He is also the Associate Director for Design and Analysis of The Ohio State University's Biostatistics Program located in the medical center. Staff from the Biostatistics program, under Dr. Pearl's supervision, will perform much of the computational aspects of the OCRPP Biostatistics Core (e.g. working with each laboratory on data quality issues, preparing data sets for analyses and assisting Dr. Pearl in statistical programming tasks related to the analyses of data).

Project Start
1999-07-01
Project End
2000-06-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Giannini, Peter J; Morse, Mark A; Weghorst, Christopher M et al. (2008) Functional Activities and Immunohistochemical Cellular Distribution of Glutathione S-Transferases in Normal, Dysplastic, and Squamous Cell Carcinoma Human Oral Tissues. Clin Med Oncol 2:159-168
Wang, Dian; Grecula, John C; Gahbauer, Reinhard A et al. (2006) p16 gene alterations in locally advanced squamous cell carcinoma of the head and neck. Oncol Rep 15:661-5
Sedghizadeh, Parish P; Mallery, Susan R; Thompson, Sarah J et al. (2006) Expression of the serine protease DESC1 correlates directly with normal keratinocyte differentiation and inversely with head and neck squamous cell carcinoma progression. Head Neck 28:432-40
Han, ChunHua; Ding, Haiming; Casto, Bruce et al. (2005) Inhibition of the growth of premalignant and malignant human oral cell lines by extracts and components of black raspberries. Nutr Cancer 51:207-17
Pasche, Boris; Knobloch, Thomas J; Bian, Yansong et al. (2005) Somatic acquisition and signaling of TGFBR1*6A in cancer. JAMA 294:1634-46
Ding, Haiming; Han, Chunhua; Zhu, Jiuxiang et al. (2005) Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9. Int J Cancer 113:803-10
Ding, Haiming; Han, Chunhua; Gibson-D'Ambrosio, Ruth et al. (2003) Piroxicam selectively inhibits the growth of premalignant and malignant human oral cell lines by limiting their progression through the S phase and reducing the levels of cyclins and AP-1. Int J Cancer 107:830-6
Smiraglia, D J; Smith, L T; Lang, J C et al. (2003) Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC). J Med Genet 40:25-33
Mallery, Susan R; Morse, Mark A; Wilson, Ralph F et al. (2003) AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion. J Cell Biochem 89:133-43
Wilson, Ralph F; Morse, Mark A; Pei, Ping et al. (2003) Endostatin inhibits migration and invasion of head and neck squamous cell carcinoma cells. Anticancer Res 23:1289-95

Showing the most recent 10 out of 24 publications